WO1999043802A3 - HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS - Google Patents

HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS Download PDF

Info

Publication number
WO1999043802A3
WO1999043802A3 PCT/JP1999/000875 JP9900875W WO9943802A3 WO 1999043802 A3 WO1999043802 A3 WO 1999043802A3 JP 9900875 W JP9900875 W JP 9900875W WO 9943802 A3 WO9943802 A3 WO 9943802A3
Authority
WO
WIPO (PCT)
Prior art keywords
proteins
transmembrane domains
human
cdnas
dnas encoding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP1999/000875
Other languages
French (fr)
Other versions
WO1999043802A2 (en
Inventor
Seishi Kato
Shingo Sekine
Tomoko Kimura
Nobuko Nakamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sagami Chemical Research Institute
Protegene Inc
Original Assignee
Sagami Chemical Research Institute
Protegene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sagami Chemical Research Institute, Protegene Inc filed Critical Sagami Chemical Research Institute
Priority to EP99905305A priority Critical patent/EP1056847A2/en
Priority to JP2000533542A priority patent/JP2002506615A/en
Priority to AU25493/99A priority patent/AU2549399A/en
Priority to CA002322711A priority patent/CA2322711A1/en
Publication of WO1999043802A2 publication Critical patent/WO1999043802A2/en
Publication of WO1999043802A3 publication Critical patent/WO1999043802A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Human proteins having transmembrane domains, cDNAs coding for these proteins, and expression vectors of said cDNAs as well as eucaryotic cells expressing said cDNAs. Said proteins and eucaryotic cells having said proteins on the membrane surface can be provided by expression of cDNAs coding for human proteins having transmembrane domains and of recombinants of these human cDNAs.
PCT/JP1999/000875 1998-02-27 1999-02-25 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS Ceased WO1999043802A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP99905305A EP1056847A2 (en) 1998-02-27 1999-02-25 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
JP2000533542A JP2002506615A (en) 1998-02-27 1999-02-25 Human protein having transmembrane domain and DNA encoding the same
AU25493/99A AU2549399A (en) 1998-02-27 1999-02-25 Human proteins having transmembrane domains and dnas encoding these proteins
CA002322711A CA2322711A1 (en) 1998-02-27 1999-02-25 Human proteins having transmembrane domains and dnas encoding these proteins

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4660798 1998-02-27
JP10/46607 1998-02-27

Publications (2)

Publication Number Publication Date
WO1999043802A2 WO1999043802A2 (en) 1999-09-02
WO1999043802A3 true WO1999043802A3 (en) 1999-12-29

Family

ID=12752001

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP1999/000875 Ceased WO1999043802A2 (en) 1998-02-27 1999-02-25 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS

Country Status (5)

Country Link
EP (1) EP1056847A2 (en)
JP (1) JP2002506615A (en)
AU (1) AU2549399A (en)
CA (1) CA2322711A1 (en)
WO (1) WO1999043802A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1017707A4 (en) * 1997-08-29 2004-04-28 Human Genome Sciences Inc 29 HUMAN SECRETED PROTEINS
PT1207168E (en) * 1997-09-17 2005-06-30 Genentech Inc POLYPEPTIDES AND NUCLEIC ACIDS THAT ENCODE THEM
US20030082541A1 (en) * 1997-09-17 2003-05-01 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
DK1241179T3 (en) * 1998-04-15 2006-12-04 Genentech Inc Human protein with in vitro antiproliferative activity.
CA2450402A1 (en) * 1998-12-22 2000-06-29 Genentech, Inc. Methods and compositions for inhibiting cancer cell growth comprising pro224
CA2412211A1 (en) * 2000-06-23 2002-01-03 Genetech, Inc. Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
JP2004516013A (en) * 2000-07-20 2004-06-03 ジェネンテック・インコーポレーテッド Compositions and methods for diagnosing and treating disorders associated with angiogenesis
CN100484568C (en) * 2003-12-11 2009-05-06 中国人民解放军军事医学科学院放射与辐射医学研究所 Antibiosis usage of a family of protein

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023548A2 (en) * 1992-05-20 1993-11-25 Vertex Pharmaceuticals Incorporated METHOD OF DETECTING TISSUE-SPECIFIC FK506 BINDING PROTEIN MESSENGER RNAs AND USES THEREOF
WO1995000633A2 (en) * 1993-06-17 1995-01-05 Children's Medical Center Corporation Construction and use of synthetic constructs encoding syndecan
WO1995034641A1 (en) * 1994-06-15 1995-12-21 The Scripps Research Institute Structural models for cytoplasmic domains of transmembrane receptors
WO1998054963A2 (en) * 1997-06-06 1998-12-10 Human Genome Sciences, Inc. 207 human secreted proteins

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023548A2 (en) * 1992-05-20 1993-11-25 Vertex Pharmaceuticals Incorporated METHOD OF DETECTING TISSUE-SPECIFIC FK506 BINDING PROTEIN MESSENGER RNAs AND USES THEREOF
WO1995000633A2 (en) * 1993-06-17 1995-01-05 Children's Medical Center Corporation Construction and use of synthetic constructs encoding syndecan
WO1995034641A1 (en) * 1994-06-15 1995-12-21 The Scripps Research Institute Structural models for cytoplasmic domains of transmembrane receptors
WO1998054963A2 (en) * 1997-06-06 1998-12-10 Human Genome Sciences, Inc. 207 human secreted proteins

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK 6 June 1997 (1997-06-06), MARRA M. ET AL.: "EST; mouse cDNA clone IMAGE:849512 similar to FK506-binding protein precursor", XP002109280 *
DATABASE SEQUENCES EMBL, Heidelberg, FRG; 3 February 1998 (1998-02-03), NAKAMURA T. ET AL.: "Mouse FK-506 binding protein (FKBP23)", XP002109279 *
NAKAMURA T. ET AL.: "Molecular cloning, characterization and chromosomal localization of FKBP23, a novel FK506-binding protein with Ca2+-binding ability.", GENOMICS, vol. 54, no. 1, November 1998 (1998-11-01), pages 89 - 98, XP004448955, DOI: doi:10.1006/geno.1998.5571 *

Also Published As

Publication number Publication date
JP2002506615A (en) 2002-03-05
WO1999043802A2 (en) 1999-09-02
AU2549399A (en) 1999-09-15
EP1056847A2 (en) 2000-12-06
CA2322711A1 (en) 1999-09-02

Similar Documents

Publication Publication Date Title
WO2000005367A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
WO2001049728A3 (en) HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
WO2000008057A3 (en) Molecules designated b7l-1
AU2002228972A1 (en) Polynucleotide encoding chimeric protein and related vectors, cells, and methods of expression thereof
WO1998021328A3 (en) Human proteins having transmembrane domains and dnas encoding these proteins
NZ510356A (en) Molecules designated LDCAM
CA2200423A1 (en) Novel estrogen receptor
WO1998021343A8 (en) Genes encoding telomerase proteins
AU2002221771A1 (en) Cation-conducting or proton-conducting ceramic membrane based on a hydroxysilylic acid, method for the production thereof and use of the same
WO2000029448A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
WO2001012660A3 (en) HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
WO1996007739A3 (en) Interleukin-1 type 3 receptors
WO2001002563A3 (en) HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
CA2336261A1 (en) Cyclin e2 genes and proteins
WO1998017810A3 (en) Multi-functional chimeric hematopoietic receptor agonists
WO1996034965A3 (en) Chimeric mcp and daf proteins with cell surface localizing domain
ZA978503B (en) Vertebrate smoothened proteins
WO1999035263A3 (en) Il-17rh dna and polypeptides
WO2001004297A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
AU3310399A (en) Leptospiral outer membrane protein, lipl32
AU1183200A (en) Novel gene encoding brain-specific membrane protein
WO2001083552A3 (en) Human sez6 nucleic acids and polypeptides
EP1045914B8 (en) Testis-specific human svph1-8 proteinase
WO1999046380A3 (en) Human membrane spanning proteins
WO1999058676A3 (en) Semaphorin polypeptides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP MX US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP MX US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 25493/99

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: PA/a/2000/008085

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 1999905305

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2322711

Country of ref document: CA

Ref country code: CA

Ref document number: 2322711

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 1999905305

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09622522

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 1999905305

Country of ref document: EP